ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising

GLENMARK NEWS reasons for why stock price of Glenmark Pharmaceuticals Limited is falling or rising

GLENMARK Glenmark Pharmaceuticals is falling or rising technical reasons

Technical analysis forecast of Glenmark Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Glenmark Pharmaceuticals GLENMARK at this time. Stock is rising and might rise more.

It appears as if Glenmark Pharmaceuticals GLENMARK gave a large move recently.

Stock of Glenmark Pharmaceuticals (GLENMARK) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

Although my analysis for Glenmark Pharmaceuticals is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 2414.7, for a target of 2351.9 or 2299.53

GLENMARK Glenmark Pharmaceuticals is falling or rising NEWS fundamental reasons

Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 21, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-D - NEWS as on 2026-08-21

Glenmark expands US injectables portfolio with Calcium Gluconate launch The product has been launched in 1,000 mg/10 mL and 5,000 mg/50 mL single-dose vials, along with a 10,000 mg/100 mL pharmacy bulk package - NEWS as on 2026-08-21 business-standard.com

Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray". - NEWS as on 2026-08-20

Glenmark receives US FDA approval for Fluticasone Propionate Nasal Spray Glenmark's Fluticasone Propionate Nasal Spray is bioequivalent and therapeutically equivalent to Flonase Nasal Spray of Haleon US Holdings LLC - NEWS as on 2026-08-20 business-standard.com

Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-08-17

Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 11, 2026 - NEWS as on 2026-08-14

Company Announcement Settlement Agreement - Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 - NEWS as on 2026-08-12

Company Announcement Intimation of Allotment of shares under the Employee Stock Option Plan 2016 - NEWS as on 2026-08-10

Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2026-08-05

Company Announcement - NEWS as on 2026-08-04

Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 31, 2026, titled "Press Release and Management Discussion & Analysis". - NEWS as on 2026-08-03

More announcements and NEWS

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2337.6
  • 12Day Average: 2314.81
  • 20Day Average: 2286.34
  • 50Day Average: 2244.97
  • 100Day Average: 2255.17
  • 150Day Average: 2189.9
  • 200Day Average: 2130.43

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2321.67, 2288.67, 21.98
Indicator MACD is in positive zone

Indicator ADX (14)

21.94, 22.73, 14.55
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
25 Tue Aug 2026 2400.00 2376.00 to 2421.00 0.39% 1.36 times
24 Mon Aug 2026 2390.70 2295.30 to 2395.00 3.14% 1.48 times
21 Fri Aug 2026 2317.90 2303.00 to 2348.60 -0.64% 0.49 times
20 Thu Aug 2026 2332.90 2252.10 to 2342.00 3.85% 1.15 times
19 Wed Aug 2026 2246.50 2222.50 to 2313.90 -2.54% 1.73 times
18 Tue Aug 2026 2305.00 2305.00 to 2332.90 -1.03% 0.79 times
17 Mon Aug 2026 2329.00 2300.00 to 2337.00 0.46% 0.63 times
14 Fri Aug 2026 2318.40 2307.20 to 2341.60 -0.07% 1.31 times
13 Thu Aug 2026 2320.00 2281.90 to 2322.90 1.31% 0.86 times
12 Wed Aug 2026 2290.00 2272.40 to 2310.00 0.62% 0.97 times
11 Tue Aug 2026 2276.00 2245.00 to 2291.00 1.1% 0.59 times
10 Mon Aug 2026 2251.30 2251.30 to 2297.80 -1.22% 0.54 times

Videos related to: GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising

 

Back to top